Literature DB >> 18508602

ATP-dependent chromatin remodeling enzymes and their various roles in cell cycle control.

Stefano Morettini1, Valerie Podhraski, Alexandra Lusser.   

Abstract

The modification of chromatin structure by various mechanisms has emerged as a key regulatory component of nuclear programs. Cell cycle progression and exit are affected by the integrity of chromatin architecture as well as by regulatory cues that chromatin structure imposes on the expression of cell cycle genes. ATP-dependent chromatin remodeling factors use the energy derived from ATP-hydrolysis to modulate histone-DNA contacts. These molecular machines play important roles in all aspects of chromosome biology and are thus intimately linked to cell cycle control. Regulation of complex activity by various signaling pathways has been a rising theme in recent years. Moreover, some chromatin remodeling factors have been characterized as potent tumor suppressor proteins. Thus, to understand the functions and activities of ATP-utilizing chromatin remodeling factors is an important goal towards their use as potential targets in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508602     DOI: 10.2741/3096

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.

Authors:  Fu-Min Fang; Chien-Feng Li; Hsuan-Ying Huang; Ming-Tsong Lai; Chih-Mei Chen; I-Wen Chiu; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih; Jim Jinn-Chyuan Sheu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Nucleosome remodeling and epigenetics.

Authors:  Peter B Becker; Jerry L Workman
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 3.  Programming DNA replication origins and chromosome organization.

Authors:  Christelle Cayrou; Philippe Coulombe; Marcel Méchali
Journal:  Chromosome Res       Date:  2010-01       Impact factor: 5.239

4.  Spaceflight/microgravity inhibits the proliferation of hematopoietic stem cells by decreasing Kit-Ras/cAMP-CREB pathway networks as evidenced by RNA-Seq assays.

Authors:  Peng Wang; Hongling Tian; Jiayu Zhang; Juanjuan Qian; Ling Li; Lu Shi; Yong Zhao
Journal:  FASEB J       Date:  2019-02-05       Impact factor: 5.191

5.  Fun30 and Rtt109 Mediate Epigenetic Regulation of the DNA Damage Response Pathway in C. albicans.

Authors:  Prashant Kumar Maurya; Pramita Garai; Kaveri Goel; Himanshu Bhatt; Anindita Dutta; Aarti Goyal; Sakshi Dewasthale; Meghna Gupta; Dominic Thangminlen Haokip; Sanju Barik; Rohini Muthuswami
Journal:  J Fungi (Basel)       Date:  2022-05-25

6.  The chromodomains of CHD1 are critical for enzymatic activity but less important for chromatin localization.

Authors:  Stefano Morettini; Martin Tribus; Anette Zeilner; Johanna Sebald; Beatriz Campo-Fernandez; Gabriele Scheran; Hildegard Wörle; Valerie Podhraski; Dmitry V Fyodorov; Alexandra Lusser
Journal:  Nucleic Acids Res       Date:  2010-12-21       Impact factor: 16.971

Review 7.  ATP-dependent chromatin remodeling factors and their roles in affecting nucleosome fiber composition.

Authors:  Paolo Piatti; Anette Zeilner; Alexandra Lusser
Journal:  Int J Mol Sci       Date:  2011-10-06       Impact factor: 5.923

8.  Global epigenetic changes induced by SWI2/SNF2 inhibitors characterize neomycin-resistant mammalian cells.

Authors:  Popy Dutta; Goutam Kumar Tanti; Soni Sharma; Shyamal K Goswami; Sneha Sudha Komath; Marty W Mayo; Joel W Hockensmith; Rohini Muthuswami
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Transcriptional Regulation of Atp-Dependent Chromatin Remodeling Factors: Smarcal1 and Brg1 Mutually Co-Regulate Each Other.

Authors:  Dominic Thangminlen Haokip; Isha Goel; Vijendra Arya; Tapan Sharma; Reshma Kumari; Rashmi Priya; Manpreet Singh; Rohini Muthuswami
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.